Sharechat Logo

F&P Healthcare extends US distribution deal

Thursday 9th February 2012

Text too small?

Fisher & Paykel Healthcare said it has renewed an exclusive US distribution agreement with global medical technology company CareFusion for a further three years.

Fisher & Paykel's president of US operations, Justin Callahan, said his company's continued partnership with CareFusion will help it to continue to grow in the US.

A CareFusion segment president, Vivek Jain, said his company and Fisher & Paykel Healthcare have been partners in bringing the latter's portfolio of respiratory consumable products to US hospitals for more than 25 years.

“As we extend and strengthen our strategic relationships with proven partners like Fisher & Paykel Healthcare, our customers benefit from continued access to market-leading technologies that help improve the cost, quality and safety of patient care,” Jain said.

In the year ended March 2011, North American sales accounted for 46 percent of Fisher & Paykel Healthcare's total sales.

Fisher & Paykel Healthcare's shares, which tend to suffer when the New Zealand dollar is strong, closed yesterday at $2.11. That's just above its year-low at $2.09 struck last month and well down from the high at $3.19 early last year.

(BusinessDesk)

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report